RGX-121-3102 Gene Therapy in Participants With MPS II (Hunter Syndrome)
Clinical trial NCT07236606 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07236606
- Sponsor
- REGENXBIO Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-25
- Primary completion
- 2028-04-30
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.